Skip to content

Clinical trials

Phase 1 Encephalitis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Encephalitis Phase: Phase 1 Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20111
20171
20181
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Not yet recruiting1
Suspended1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Arialys Therapeutics2
National Institute of Allergy and Infectious Diseases (NIAID)2
California Pacific Medical Center Research Institute1
Inviragen Inc.1
Pfizer1
SRI International1
Sarepta Therapeutics, Inc.1
Stony Brook University1
University of California, Los Angeles1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Encephalitis11
HIV Infections3
Autoimmune Diseases of the Nervous System2
Brain Diseases2
Toxoplasmosis2
Toxoplasmosis, Cerebral2
AIDS-Related Opportunistic Infections1
Acquired Immunodeficiency Syndrome1
Alphavirus Infections1
Autism Spectrum Disorder1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.